메뉴펼치기
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
해당 자료는 4페이지 까지만 미리보기를 제공합니다.
4페이지 이후부터 다운로드 후 확인할 수 있습니다.
4페이지 이후부터 다운로드 후 확인할 수 있습니다.
목차
목차
1. 다제내성 원내 감염균의 종류
1) MRSA (메티실린내성황색포도알균)
2) VRE (반코마이신내성장알균)
3) VRSA (반코마이신내성황색포도알균)
4) MRAB (다제내성아시네토박터바우마니균)
5) CRE (카바페넴내성장내세균속균종)
6) MRPA (다제내성녹농균)
2. 감염관리/치료 방법
3. 시사점 및 고찰
4. 출처 및 참고문헌
1. 다제내성 원내 감염균의 종류
1) MRSA (메티실린내성황색포도알균)
2) VRE (반코마이신내성장알균)
3) VRSA (반코마이신내성황색포도알균)
4) MRAB (다제내성아시네토박터바우마니균)
5) CRE (카바페넴내성장내세균속균종)
6) MRPA (다제내성녹농균)
2. 감염관리/치료 방법
3. 시사점 및 고찰
4. 출처 및 참고문헌
본문내용
orea. Korean J Nosocomial Infect Control 1997;2:157-76.
[7] Lee SB, Lee WC, Jung HC, Song SH, Lee DW, Kim YB, et al. Clinical characteristics and prognostic factors of bacteremia and sepsis. Korean J Med 1999;56:347-58.
[8] Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG. A com parison of clinical features and mortality among me thicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 2005;46:496-502.
[9] Kim SH, Ryu JH, Kim MS, Choi HJ. The risk factors and prognosis of methicillin-resistant Staphylococcus aureus bacteremia: focus on nosocomial acquisition. Korean J Med 2006;71:405-14.
[10] Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Sta phylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-74.
[11] Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and eco nomic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
[12] Chong Y. Antimicrobial susceptibilities of recent clinical isolates of bacteria. J Korean Soc Chemother 1991;9:5-11.
[13] Lee HK, Lee WG, Cho SR. Clinical and molecular biological analysis of a nosocomial outbreak of vanco mycin- resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999;88:651-4.
[14] Lee K, Kim YA, Park YJ, Lee HS, Kim MY, Kim EC, et al. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroqui nolone-resistant gram-negative bacilli: a KONSAR study in 2002. Yonsei Med J 2004;45:598-608.
[15] Yoo SJ, Sung H, Cho YU, Kim MN, Pai CH, Kim YS. Role of horizontal transfer of the transposon Tn1546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea. Infect Control Hosp Epidemiol 2006;27:1081-7.
[16] Kim HB, Kim NJ, Lee SH, Kim T, Kim US, Oh MD, et al. Prevalence of Staphylococcus aureus with reduced sus ceptibility to vancomycin in a tertiary hospital. Korean J Infect Dis 2000;32:294-300.
[17] Kim HB, Lee YS, Kim BS, Cha JO, Kwon SU, Lee HJ, et al. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea. Microb Drug Resist 2006;12:33-8.
[18] Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CK, et al. Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients. Infect Control Hosp Epidemiol 2009; 30:130-8.
[19] 질병관리본부. (2012). 「중환자실의 MRAB(Multi-drug resistant Acinetoacter bauma nnii) 감염 위험 요인 분석」. 학술연구용역사업 연구보고서.
[20] 박주경. (2020). 일반병동 입원 환자의 입원 시 카바페넴내성장내세균속균종(carbap enem-resistant Enterobacteriaceae, CRE) 보유율과 위험요인. 울산대학교 산업대학원 석사학위 논문.
[21] 김미나. (2011). 다제내성균과 의료 관련 감염., 31(3), 141-152.
[7] Lee SB, Lee WC, Jung HC, Song SH, Lee DW, Kim YB, et al. Clinical characteristics and prognostic factors of bacteremia and sepsis. Korean J Med 1999;56:347-58.
[8] Yoon HJ, Choi JY, Kim CO, Kim JM, Song YG. A com parison of clinical features and mortality among me thicillin-resistant and methicillin-sensitive strains of Staphylococcus aureus endocarditis. Yonsei Med J 2005;46:496-502.
[9] Kim SH, Ryu JH, Kim MS, Choi HJ. The risk factors and prognosis of methicillin-resistant Staphylococcus aureus bacteremia: focus on nosocomial acquisition. Korean J Med 2006;71:405-14.
[10] Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Sta phylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-74.
[11] Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and eco nomic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-8.
[12] Chong Y. Antimicrobial susceptibilities of recent clinical isolates of bacteria. J Korean Soc Chemother 1991;9:5-11.
[13] Lee HK, Lee WG, Cho SR. Clinical and molecular biological analysis of a nosocomial outbreak of vanco mycin- resistant enterococci in a neonatal intensive care unit. Acta Paediatr 1999;88:651-4.
[14] Lee K, Kim YA, Park YJ, Lee HS, Kim MY, Kim EC, et al. Increasing prevalence of vancomycin-resistant enterococci, and cefoxitin-, imipenem- and fluoroqui nolone-resistant gram-negative bacilli: a KONSAR study in 2002. Yonsei Med J 2004;45:598-608.
[15] Yoo SJ, Sung H, Cho YU, Kim MN, Pai CH, Kim YS. Role of horizontal transfer of the transposon Tn1546 in the nosocomial spread of vanA vancomycin-resistant enterococci at a tertiary care hospital in Korea. Infect Control Hosp Epidemiol 2006;27:1081-7.
[16] Kim HB, Kim NJ, Lee SH, Kim T, Kim US, Oh MD, et al. Prevalence of Staphylococcus aureus with reduced sus ceptibility to vancomycin in a tertiary hospital. Korean J Infect Dis 2000;32:294-300.
[17] Kim HB, Lee YS, Kim BS, Cha JO, Kwon SU, Lee HJ, et al. Prevalence and clinical implications of Staphylococcus aureus with a vancomycin MIC of 4 microg/ml in Korea. Microb Drug Resist 2006;12:33-8.
[18] Han SH, Chin BS, Lee HS, Jeong SJ, Choi HK, Kim CK, et al. Recovery of both vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus from culture of a single clinical specimen from colonized or infected patients. Infect Control Hosp Epidemiol 2009; 30:130-8.
[19] 질병관리본부. (2012). 「중환자실의 MRAB(Multi-drug resistant Acinetoacter bauma nnii) 감염 위험 요인 분석」. 학술연구용역사업 연구보고서.
[20] 박주경. (2020). 일반병동 입원 환자의 입원 시 카바페넴내성장내세균속균종(carbap enem-resistant Enterobacteriaceae, CRE) 보유율과 위험요인. 울산대학교 산업대학원 석사학위 논문.
[21] 김미나. (2011). 다제내성균과 의료 관련 감염.
추천자료
- 가격4,500원
- 페이지수13페이지
- 등록일2024.01.02
- 저작시기2024.01
- 파일형식한글(hwp)
- 자료번호#1234337
본 자료는 최근 2주간 다운받은 회원이 없습니다.
소개글